ATE276355T1 - Verfahren zur konservierung von biologisch aktivem material - Google Patents
Verfahren zur konservierung von biologisch aktivem materialInfo
- Publication number
- ATE276355T1 ATE276355T1 AT00938911T AT00938911T ATE276355T1 AT E276355 T1 ATE276355 T1 AT E276355T1 AT 00938911 T AT00938911 T AT 00938911T AT 00938911 T AT00938911 T AT 00938911T AT E276355 T1 ATE276355 T1 AT E276355T1
- Authority
- AT
- Austria
- Prior art keywords
- active material
- preserved
- biologically
- biologically active
- coacervate
- Prior art date
Links
- 239000011149 active material Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 abstract 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 abstract 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 abstract 2
- 238000004108 freeze drying Methods 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 229920001661 Chitosan Polymers 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9914412.3A GB9914412D0 (en) | 1999-06-22 | 1999-06-22 | Method for the preservation of viruses,bacteria and biomolecules |
| PCT/GB2000/002254 WO2000078924A1 (en) | 1999-06-22 | 2000-06-21 | Method for the preservation of biologically-active material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE276355T1 true ATE276355T1 (de) | 2004-10-15 |
Family
ID=10855729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00938911T ATE276355T1 (de) | 1999-06-22 | 2000-06-21 | Verfahren zur konservierung von biologisch aktivem material |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6841168B1 (de) |
| EP (1) | EP1187907B1 (de) |
| CN (1) | CN1168819C (de) |
| AT (1) | ATE276355T1 (de) |
| AU (1) | AU5413500A (de) |
| DE (1) | DE60013821T2 (de) |
| ES (1) | ES2228540T3 (de) |
| GB (1) | GB9914412D0 (de) |
| WO (1) | WO2000078924A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080064108A1 (en) * | 1997-12-10 | 2008-03-13 | Tony Baker | Urine Preservation System |
| US7569342B2 (en) * | 1997-12-10 | 2009-08-04 | Sierra Molecular Corp. | Removal of molecular assay interferences |
| AU2003230908A1 (en) * | 2002-04-11 | 2003-10-27 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
| US20050118058A1 (en) * | 2003-12-01 | 2005-06-02 | Erning Xia | Gentle preservative compositions for self-preserving solutions |
| CA2569276C (en) * | 2004-06-02 | 2018-01-23 | Victor Bronshtein | Preservation by vaporization |
| GB0517688D0 (en) * | 2005-08-31 | 2005-10-05 | Cambridge Biostability Ltd | Improvements in the stabilisation of biological materials |
| CN100375636C (zh) * | 2005-09-29 | 2008-03-19 | 中国农业大学 | 一种对微生态制剂有保护作用的糖类组合物的用途 |
| GB0523638D0 (en) | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
| AU2007221154A1 (en) * | 2006-02-24 | 2007-09-07 | Novartis Ag | Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| US8399230B2 (en) * | 2006-10-12 | 2013-03-19 | Kemin Industries, Inc. | Heat-stable enzyme compositions |
| US20090081785A1 (en) | 2007-09-24 | 2009-03-26 | Hememics Biotechnologies, Inc. | Desiccated Biologics And Methods Of Preparing The Same |
| US20090090022A1 (en) * | 2007-10-09 | 2009-04-09 | Hememics Biotechnologies, Inc. | Desiccation Chamber and Methods for Drying Biological Materials |
| GB0900350D0 (en) * | 2009-01-09 | 2009-02-11 | Cambridge Entpr Ltd | Formulations of viable bacteria for oral delivery |
| JP5804453B2 (ja) * | 2009-05-14 | 2015-11-04 | 国立大学法人 東京大学 | 結晶性ポリオール微粒子及びその調製方法 |
| EP2547760A4 (de) | 2010-02-17 | 2014-01-01 | Hememics Biotechnologies Inc | Konservierungslösungen für biologika und zugehörige verfahren |
| SG187250A1 (en) * | 2010-08-13 | 2013-03-28 | Advanced Bionutrition Corp | Dry storage stabilizing composition for biological materials |
| GB201101950D0 (en) * | 2011-02-04 | 2011-03-23 | Anhydro Ltd | Vaccine compositions |
| US8512679B2 (en) | 2011-03-04 | 2013-08-20 | Elwha Llc | Glassy compositions |
| SG11201401360XA (en) | 2011-10-25 | 2014-05-29 | Onclave Therapeutics Ltd | Antibody formulations and methods |
| WO2016210251A1 (en) | 2015-06-25 | 2016-12-29 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| US10851399B2 (en) | 2015-06-25 | 2020-12-01 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| US9938558B2 (en) | 2015-06-25 | 2018-04-10 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
| NZ743958A (en) | 2016-01-07 | 2023-07-28 | Native Microbials Inc | Methods for improving milk production by administration of microbial consortia |
| JP2020504620A (ja) | 2016-12-28 | 2020-02-13 | アスカス バイオサイエンシーズ， インコーポレイテッド | 複雑な不均一コミュニティの完全微生物株の解析、その機能的関連性及び相互作用の決定、ならびにそれに基づく生物反応性の改変剤の同定及び合成、のための方法、装置、及びシステム |
| AU2017388535A1 (en) | 2016-12-28 | 2019-07-25 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles including dosed microbial ensembles and inoculative microbial ensembles |
| EP3614847A4 (de) | 2017-04-28 | 2021-09-01 | Native Microbials, Inc. | Verfahren zur unterstützung von getreideintensiver und energieintensiver ernährung bei wiederkäuern mit synthetischem bioensemble von mikroben |
| US20230323332A1 (en) * | 2020-08-28 | 2023-10-12 | Chr. Hansen A/S | Microencapsulation of microbial culture using octenyl succinic anhydride starch-chitosan complex coacervate |
| CN112471476A (zh) * | 2020-11-18 | 2021-03-12 | 山东丰香园食品股份有限公司 | 一种具有补脑及美白作用的芝麻粉及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ226170A (en) * | 1987-09-18 | 1990-07-26 | Ethicon Inc | Stable freeze-dried pharmaceutical composition containing epidermal growth factor |
| GB8801338D0 (en) * | 1988-01-21 | 1988-02-17 | Quadrant Bioresources Ltd | Preservation of viruses |
| GB9125695D0 (en) * | 1991-12-03 | 1992-01-29 | Mastavac Limited | Medical preparations |
| FR2694895B1 (fr) * | 1992-08-20 | 1994-11-10 | Coletica | Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification. |
| EP1649850A1 (de) * | 1993-11-19 | 2006-04-26 | Alkermes Controlled Therapeutics Inc. II | Herstellung biodegradierbarer Mikroteilchen, die ein biologisch aktives Mittel enthalten |
| BR9609188A (pt) * | 1995-06-07 | 1999-05-11 | Quadrant Holdings Cambridge | Métodos para incorporar substâncias de modo estável dentro de matrizes de vidro espumado secas e composições obtidas desse modo |
| US5900238A (en) * | 1995-07-27 | 1999-05-04 | Immunex Corporation | Vaccine delivery system |
| GB9522351D0 (en) * | 1995-11-01 | 1996-01-03 | Medeva Holdings Bv | Vaccine compositions |
| GB9525083D0 (en) * | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
| JP2000514440A (ja) * | 1996-07-09 | 2000-10-31 | ザ ジョーンズ ホプキンス ユニバーシティー | 遺伝子輸送システム |
| DE69810755T2 (de) * | 1997-02-07 | 2003-08-07 | Elan Drug Delivery Ltd | Verfahren und zusammensetzungen zur herstellung getrockneter, lagerungsstabiler blutplättchen |
| WO1999027071A1 (en) * | 1997-11-26 | 1999-06-03 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
-
1999
- 1999-06-22 GB GBGB9914412.3A patent/GB9914412D0/en not_active Ceased
-
2000
- 2000-06-21 WO PCT/GB2000/002254 patent/WO2000078924A1/en active IP Right Grant
- 2000-06-21 AT AT00938911T patent/ATE276355T1/de not_active IP Right Cessation
- 2000-06-21 US US10/018,834 patent/US6841168B1/en not_active Expired - Fee Related
- 2000-06-21 AU AU54135/00A patent/AU5413500A/en not_active Abandoned
- 2000-06-21 DE DE60013821T patent/DE60013821T2/de not_active Expired - Fee Related
- 2000-06-21 EP EP00938911A patent/EP1187907B1/de not_active Expired - Lifetime
- 2000-06-21 CN CNB008093288A patent/CN1168819C/zh not_active Expired - Fee Related
- 2000-06-21 ES ES00938911T patent/ES2228540T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000078924A1 (en) | 2000-12-28 |
| EP1187907B1 (de) | 2004-09-15 |
| EP1187907A1 (de) | 2002-03-20 |
| DE60013821D1 (de) | 2004-10-21 |
| US6841168B1 (en) | 2005-01-11 |
| CN1168819C (zh) | 2004-09-29 |
| AU5413500A (en) | 2001-01-09 |
| DE60013821T2 (de) | 2005-11-17 |
| ES2228540T3 (es) | 2005-04-16 |
| CN1357037A (zh) | 2002-07-03 |
| GB9914412D0 (en) | 1999-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE276355T1 (de) | Verfahren zur konservierung von biologisch aktivem material | |
| AP1521A (en) | Method for the preservation of viruses and mycoplasma. | |
| AR248426A1 (es) | Produccion de particulas incorporadas a un virus vegetal que contiene un peptido antigenico, con el fin de preparar una vacuna de virus animal. | |
| BR9611265A (pt) | Preparações e processos para estabilização de materiais biológicos por meio de processos de secagem sem congelamento | |
| JP2015145500A5 (de) | ||
| ATE164515T1 (de) | Herstellung von liposomen und verfahren zur substanzverkapselung | |
| AR010036A1 (es) | Composicion y metodo para tratar plantas con compuestos quimicos exogenos. | |
| DE69740002D1 (de) | Tierzellen und verfahren für die replikation von influenza viren | |
| ES8106407A1 (es) | Procedimiento para el tratamiento de superficies hidrofobas | |
| DE69819124D1 (de) | Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna | |
| DK570588A (da) | Koncentrerede vandige oploesninger af antibiotiket vancomycin-hydrochlorid og fremgangsmaade til lyophilisering deraf | |
| DE3888943D1 (de) | Verfahren zur Verkapselung. | |
| MY186730A (en) | A method for producing aerobic-type single cell protein using the autolysis process | |
| GB2020976A (en) | Microbial inseticides | |
| ATE340272T1 (de) | In gegenwart von collagen und disacchariden lyophilisierte nukleinsäuren umfassende zusammensetzung | |
| CN107335088A (zh) | 一种可采用自体的毛发制作伤口敷料的方法 | |
| BR9813185A (pt) | Processo para remoção das micotoxinas a partir de um carregamento de café verde | |
| RU98107302A (ru) | Способ изготовления известково-песчаных строительных материалов | |
| DE68918269D1 (de) | Pflanzenvirusbekämpfungsmittel und verfahren zur herstellung. | |
| TH23870A (th) | วัคซีนและวิธีสำหรับการเตรียม | |
| ATE16951T1 (de) | Herstellungsverfahren fuer verankerungskoerper zur verankerung im boden insbesondere von pfaehlen oder pfloecken, und verankerungskoerper erhalten mittels des genannten verfahrens. | |
| EMMELIN et al. | TREATMENT OF SALT DAMAGE IN STONE AND BRICKWORK | |
| NO941377L (no) | Cellesykluskontrollerende preparater og fremgangsmåte for anvendelse av slike | |
| RU96106117A (ru) | Способ получения живой коревой вакцины | |
| RU2002134730A (ru) | Способ получения трипсина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |